Dataset Information

Comparison between Collagen and Lidocaine Intramuscular Injections in Terms of Their Efficiency in Decreasing Myofascial Pain within Masseter Muscles: A Randomized, Single-Blind Controlled Trial.

ABSTRACT: Background and Objective:A novel option for myofascial pain (MFP) management and muscle regeneration is intramuscular collagen injections. The aim of the study was to evaluate the efficiency of intramuscular injections of collagen and lidocaine in decreasing MFP within masseter muscles. Methods:Myofascial pain within masseter muscles was diagnosed on the basis of the Diagnostic Criteria for Temporomandibular Disorders (II.1.A. 2 and 3). A total of 43 patients with diagnosed MFP within masseter muscles were enrolled to the study (17 male and 26 female, 40?±?3.8 years old) and randomly divided into three groups. The first group received injections using 2?ml of collagen MD Muscle (Guna), the second group received 2?ml of 2% lidocaine without a vasoconstrictor, and the third group 2?ml of saline as a control (0.9% NaCl). All patients received repeated injections at one-week intervals (days 0 and 7). The visual analogue scale was used to determine pain intensity changes during each follow-up visit (days 0, 7, and 14) in each group. The masseter muscle activity was measured on each visit (days 0, 7, and 14) with surface electromyography (sEMG) (Neurobit Optima 4, Neurobit Systems). Results:We found that sEMG masseter muscle activity was significantly decreased in Group I (59.2%), less in Group II (39.3%), and least in Group III (14%). Pain intensity reduction was 53.75% in Group I, 25% in Group II, and 20.1% in Group III. Conclusions:The study confirmed that intramuscular injection of collagen is a more efficient method for reducing myofascial pain within masseter muscles than intramuscular injection of lidocaine.

SUBMITTER: Nitecka-Buchta A

PROVIDER: S-EPMC6008702 | biostudies-literature | 2018

REPOSITORIES: biostudies-literature

ACCESS DATA

Publications

Comparison between Collagen and Lidocaine Intramuscular Injections in Terms of Their Efficiency in Decreasing Myofascial Pain within Masseter Muscles: A Randomized, Single-Blind Controlled Trial.

Nitecka-Buchta Aleksandra A Walczynska-Dragon Karolina K Batko-Kapustecka Jolanta J Wieckiewicz Mieszko M

Pain research & management 20180603

<h4>Background and objective</h4>A novel option for myofascial pain (MFP) management and muscle regeneration is intramuscular collagen injections. The aim of the study was to evaluate the efficiency of intramuscular injections of collagen and lidocaine in decreasing MFP within masseter muscles.<h4>Methods</h4>Myofascial pain within masseter muscles was diagnosed on the basis of the Diagnostic Criteria for Temporomandibular Disorders (II.1.A. 2 and 3). A total of 43 patients with diagnosed MFP wi ...[more]

PMID: 29973970

Similar Datasets

Project description:The passive load bearing properties of muscle are poorly understood partly due to challenges in identifying the connective tissue structures that bear loads. Prior attempts to correlate passive mechanical properties with collagen content (often expressed as a mass ratio and used as a surrogate for connective tissue quantity within muscle) have not been successful. This is likely a result of not accounting for variability in intramuscular connective tissue throughout a muscle such that a single collagen content value likely does not adequately represent the connective tissue load bearing capacity of a muscle. Therefore, the purpose of this study was to determine how intramuscular connective tissue distribution throughout a muscle impacts measured collagen content. For this analysis, four mouse hindlimb muscles were chosen because of their varying actions and anatomy; rectus femoris, semimembranosus, tibialis anterior, and lateral gastrocnemius. Collagen content throughout each muscle was determined biochemically using an optimized hydroxyproline assay. Dense connective tissue distribution throughout each muscle's length was quantified histologically. We found that collagen content varied widely within and between muscles, from 3.6 ± 0.40 SEM μg/mg wet weight to 15.6 ± 1.58 SEM μg/mg, which is dependent on both the specific location within a muscle and particular muscle studied. Both collagen content and connective tissue structures demonstrated stereotypically patterns with the highest quantity at the proximal and distal ends of the muscles. Additionally, using three independent approaches: (1) linear regression, (2) predictive modeling, and (3) non-linear optimization, we found complementary and corroborating evidence suggesting a causal relationship between a muscle's connective tissue distribution and collagen content. Specifically, we found that muscle collagen content is driven primarily by its dense connective tissue structures due to the extremely high collagen content of connective tissue (227.52-334.69 μg/mg) compared to muscle tissue (1.93-4.03 μg/mg). A consequence of these findings is that a single collagen content measurement does not accurately represent a muscle's complex distribution of connective tissue. Future studies should account for collagen content variations and connective tissue anatomy to establish more accurate relationships between collagen content measurements and whole muscle passive mechanics.

Dataset Information

Comparison between Collagen and Lidocaine Intramuscular Injections in Terms of Their Efficiency in Decreasing Myofascial Pain within Masseter Muscles: A Randomized, Single-Blind Controlled Trial.

Publications

Comparison between Collagen and Lidocaine Intramuscular Injections in Terms of Their Efficiency in Decreasing Myofascial Pain within Masseter Muscles: A Randomized, Single-Blind Controlled Trial.

Similar Datasets

OmicsDI is part of the ELIXIR infrastructure

Tweets